CTOs on the Move

Cvrx

www.cvrx.com

 
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cvrx.com
  • 9201 W Broadway Ave Ste 650
    Minneapolis, MN USA 55445
  • Phone: 763.416.2840

Executives

Name Title Contact Details
Brent Binkowski
 Chief Operating Officer Profile
Rick Mueller
 Director of Information Technology Profile

Funding

Cvrx raised $93M on 08/09/2016
Cvrx raised $93M on 06/03/2019
Cvrx raised $50M on 07/07/2020

Similar Companies

Associated Radiologist P.A.

Associated Radiologist P.A. is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Voyant Health

Voyant Health is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tulsa Gamma Ray Inc

Tulsa Gamma Ray Inc is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Silk Road Medical

Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention.

Fortimedix Surgical

Fortimedix Surgical is a fast growing medical device company with the ambition to inspire a new wave of technological advancement in the field of minimally invasive surgery. The company is headquartered in Nuth, The Netherlands, and has a US subsidiary in San Diego, CA. With a strong history as a global market leader in contract stent manufacturing, Fortimedix has been a trusted partner in the medical device industry for over 15 years. Building on our established position as a stent industry leader with state-of-the-art manufacturing capabilities, we have in-house control over the manufacturing of key components of our products, including the symphonX™ Surgical Platform. Thanks to our network within the medical device industry, we are able to work with various professional service providers for the supply of other platform components and services. This allows us to outsource cost by leveraging their expertise and infrastructure.